These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 478636)

  • 41. [Rabies antibodies in ferrets after a single rabies vaccination].
    Mainka C; Heber L; Schneider W
    Zentralbl Veterinarmed B; 1988 Jan; 35(1):24-8. PubMed ID: 3376624
    [No Abstract]   [Full Text] [Related]  

  • 42. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

  • 46. Ovine anti-rabies antibody production and evaluation.
    Redwan el-RM; Fahmy A; El Hanafy A; Abd El-Baky N; Sallam SM
    Comp Immunol Microbiol Infect Dis; 2009 Jan; 32(1):9-19. PubMed ID: 18242705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro.
    Lodmell DL; Esposito JJ; Ewalt LC
    J Virol; 1993 Oct; 67(10):6080-6. PubMed ID: 8371354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rabies Vaccine Adsorbed: neutralizing antibody titers after three-dose pre-exposure vaccination.
    Berlin BS
    Am J Public Health; 1990 Apr; 80(4):476-8. PubMed ID: 2316774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of cellular and humoral immunity as well as of resistance to the rabies virus in rabies vaccination].
    Gribencha SV; Ignat'ev GM; Kirkin AF; Barinskiĭ IF
    Vopr Virusol; 1985; 30(3):358-62. PubMed ID: 4049846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.].
    Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA
    Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of brain-associated rabies neutralizing substance.
    Gough PM; Dierks RE; Russell RM; Archer BG
    J Infect Dis; 1974 Apr; 129(4):456-60. PubMed ID: 4206247
    [No Abstract]   [Full Text] [Related]  

  • 54. Possible origin of CSF antibodies induced by intrathecal immunization and prophylactic effects against intracerebral rabies virus infection.
    Aoshima K; Sunden Y; Ishida S; Ochiai K; Umemura T
    J Vet Med Sci; 2011 Oct; 73(10):1303-8. PubMed ID: 21646749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees.
    Perrin P; Joffret ML; Zanetti C; Bourhy H; Gontier C; Fritzell C; Leclerc C; Sureau P
    Vaccine; 1991 Aug; 9(8):549-58. PubMed ID: 1771968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines.
    Albas A; Pardo PE; Gomes AA; Bernardi F; Ito FH
    Rev Soc Bras Med Trop; 1998; 31(4):367-71. PubMed ID: 9662964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exhaustive Exercise Does Not Affect Humoral Immunity and Protection after Rabies Vaccination in a Mouse Model.
    Xia L; Li M; Zhang Y; Ruan J; Pei J; Shi J; Fu ZF; Zhao L; Zhou M; Tian D
    Virol Sin; 2018 Jun; 33(3):241-248. PubMed ID: 29594957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.
    Turner GS
    J Gen Virol; 1978 Sep; 40(3):595-604. PubMed ID: 690611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
    Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.